Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Waters Community
NYSE:WAT Community
1
Narratives
written by author
0
Comments
on narratives written by author
18
Fair Values set
on narratives written by author
Create a narrative
Waters
Popular
Undervalued
Overvalued
Community Investing Ideas
Waters
AN
AnalystConsensusTarget
Consensus Narrative from 16 Analysts
New LC-MS Launches Will Strengthen Pharma Application Presence
Key Takeaways Focus on innovative products and strong customer relationships enhances revenue growth from instrument replacement and premium pricing, boosting net margins. Regulatory trends and emerging market expansion, along with operational agility, drive revenue and stabilize earnings despite external challenges.
View narrative
US$373.98
FV
20.0% undervalued
intrinsic discount
6.66%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
10
users have followed this narrative
25 minutes ago
author updated this narrative
Your Valuation for
WAT
WAT
Waters
Your Fair Value
US$
Current Price
US$299.07
4.7% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
4b
2015
2018
2021
2024
2025
2027
2030
Revenue US$4.0b
Earnings US$890.7m
Advanced
Set Fair Value